Mounjaro®
Dual-agonist support that helps curb appetite, hunger, and cravings to drive substantial, sustained weight loss.
- ~22.5% average body weight loss
- Significant weight reduction
- Improves blood sugar levels
- Clinically proven weight loss

Does Victoza give you diarrhoea? Yes, diarrhoea is a very common side effect of Victoza (liraglutide), a GLP-1 receptor agonist used to treat type 2 diabetes in the UK. This gastrointestinal symptom affects more than 1 in 10 patients and typically occurs when starting treatment or increasing the dose. Whilst often troublesome, diarrhoea usually improves as the body adjusts to the medication. Understanding why this occurs, how to manage it, and when to seek medical advice can help you continue your diabetes treatment safely and effectively.
Summary: Victoza (liraglutide) commonly causes diarrhoea in more than 1 in 10 patients, particularly when starting treatment or increasing the dose.
Victoza (liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus. Yes, Victoza can cause diarrhoea, and this is recognised as one of the more common gastrointestinal side effects associated with this medication.
The mechanism behind this adverse effect relates to how liraglutide works in the body. GLP-1 receptor agonists slow gastric emptying and affect gut motility, which helps regulate blood glucose levels by delaying the absorption of nutrients. However, these same actions on the gastrointestinal tract can lead to various digestive symptoms, including diarrhoea, nausea, and abdominal discomfort.
According to the Summary of Product Characteristics (SmPC) for Victoza, diarrhoea is classified as a very common side effect, meaning it affects more than 1 in 10 people taking the medication. The gastrointestinal effects are typically most pronounced when starting treatment or increasing the dose, and they often improve over time as the body adjusts to the medication.
It is important to understand that whilst diarrhoea can be troublesome, it does not necessarily mean you need to stop taking Victoza. Many patients find that symptoms settle within the first few weeks of treatment. However, persistent or severe diarrhoea requires medical assessment, as it can lead to dehydration and electrolyte imbalances, potentially affecting kidney function, particularly in vulnerable individuals or those taking other medications that affect fluid balance.
Clinical trial data and post-marketing surveillance provide clear evidence about the frequency of diarrhoea in patients taking Victoza. According to the MHRA-approved product information, diarrhoea is classified as a very common adverse reaction, affecting at least 1 in 10 patients.
The likelihood of experiencing diarrhoea appears to be influenced by several factors:
Dose escalation: Patients are more likely to experience gastrointestinal symptoms, including diarrhoea, when initiating treatment or increasing the dose. The standard titration schedule for Victoza begins at 0.6 mg daily for at least one week before increasing to 1.2 mg, with a possible further increase to 1.8 mg if needed. This gradual approach helps minimise side effects. It's worth noting that the 0.6 mg dose is primarily for tolerability and is not considered effective for glycaemic control.
Individual susceptibility: Some patients are more prone to gastrointestinal disturbances than others, potentially related to baseline gut sensitivity, concurrent medications, or dietary factors.
Duration of treatment: For most patients, diarrhoea tends to be most problematic during the initial period of treatment and during dose increases. Gastrointestinal side effects typically diminish over time, with many patients reporting improvement or complete resolution after an adjustment period.
It is worth noting that whilst diarrhoea is common, severe or persistent diarrhoea is less frequent. Most cases are mild to moderate in intensity and self-limiting. However, the impact on quality of life can vary considerably between individuals, and what one patient finds manageable, another may find significantly disruptive to daily activities.
If you experience diarrhoea whilst taking Victoza, there are several practical strategies that may help manage this side effect whilst continuing your diabetes treatment.
Dietary modifications can play an important role:
Avoid fatty, spicy, or heavily processed foods that may exacerbate gastrointestinal symptoms
Eat smaller, more frequent meals rather than large portions
Increase soluble fibre intake gradually (oats, bananas, rice) which can help firm stools
Limit caffeine and alcohol, both of which can worsen diarrhoea
Keep a food diary to identify potential trigger foods
Hydration is crucial when experiencing diarrhoea. Ensure you drink plenty of fluids throughout the day—water is ideal, but oral rehydration solutions available from pharmacies can help replace lost electrolytes if diarrhoea is frequent. This is particularly important for older adults and those with other health conditions.
Medication timing may also help. Some patients find that taking Victoza at a consistent time each day, preferably when they can be near toilet facilities if needed, reduces anxiety and practical difficulties. The injection can be given at any time of day, with or without meals, so discuss with your healthcare team whether adjusting the timing might help.
Over-the-counter remedies such as loperamide may provide short-term relief for mild diarrhoea, but should not be used if you have bloody stools, high fever, or severe abdominal pain. Do not use for longer than 48 hours without medical advice. Consult your GP or pharmacist before using anti-diarrhoeal medications, as they can mask symptoms that require medical attention. Never adjust your Victoza dose without medical supervision.
If you also take insulin or sulfonylureas (such as gliclazide), be aware that reduced food intake due to diarrhoea may increase your risk of hypoglycaemia. Monitor your blood glucose more frequently and seek advice if needed.
Communication with your diabetes team is essential. If diarrhoea persists or significantly impacts your quality of life, your prescriber may consider temporarily reducing the dose, slowing the titration schedule, or discussing alternative treatment options. NICE guidance on type 2 diabetes management acknowledges that treatment should be individualised, and tolerability is an important consideration in medication selection.
Whilst mild diarrhoea is a recognised side effect of Victoza that often improves with time, certain symptoms warrant prompt medical attention. You should contact your GP or healthcare provider if you experience:
Severe or persistent diarrhoea lasting more than 2–3 days, or diarrhoea that is not improving after several weeks of treatment
Signs of dehydration, including excessive thirst, dark urine, dizziness, reduced urination, or feeling faint when standing
Blood in your stools or black, tarry stools
Severe abdominal pain, particularly if accompanied by fever or vomiting
Inability to keep down fluids due to concurrent vomiting
Symptoms of pancreatitis: severe, persistent abdominal pain that may radiate to the back, often accompanied by nausea and vomiting (this is a rare but serious side effect of GLP-1 receptor agonists)
If you develop symptoms suggestive of pancreatitis, stop taking Victoza immediately and seek urgent medical attention. This is explicitly advised in the product information.
Special considerations apply to certain patient groups. Older adults, those with kidney problems, and patients taking other medications (particularly diuretics, ACE inhibitors, or NSAIDs) are at higher risk of complications from diarrhoea-related dehydration and should seek advice earlier.
If you are experiencing problematic side effects, do not simply stop taking Victoza without medical advice unless you suspect pancreatitis. Abruptly discontinuing diabetes medication can lead to poor glycaemic control. Your GP or diabetes specialist can assess whether the benefits of continuing Victoza outweigh the side effects, consider dose adjustments, or discuss alternative GLP-1 receptor agonists or other diabetes medications that you may tolerate better.
For urgent concerns, particularly signs of severe dehydration, pancreatitis, or other serious symptoms, contact NHS 111 or seek same-day medical attention. Call 999 or go to A&E if you experience severe dehydration with collapse or confusion, or if you become seriously unwell. Always report side effects via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk), which helps monitor the safety of medicines used in the UK.
Diarrhoea from Victoza is usually most pronounced during the first few weeks of treatment or after dose increases, and typically improves as your body adjusts to the medication. Most patients experience resolution or significant improvement within several weeks.
Over-the-counter loperamide may provide short-term relief for mild diarrhoea, but consult your GP or pharmacist first. Do not use for longer than 48 hours without medical advice, and avoid if you have bloody stools, high fever, or severe abdominal pain.
Do not stop Victoza without medical advice unless you suspect pancreatitis (severe, persistent abdominal pain). Mild diarrhoea often improves with time and dietary adjustments, but contact your GP if symptoms are severe, persistent, or accompanied by signs of dehydration.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript